The effect of breakfast on the oral bioavailability of tacrolimus in diabetic and nondiabetic patients before transplantation

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1268-1270

  Van Duijnhoven, E ^b   Christiaans, M ^a   Undre, N ^b   Stevenson, P ^b   Van Hooff, J ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; AREA UNDER THE CURVE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; HUMAN; KIDNEY TRANSPLANTATION; MEAL; ORAL DRUG ADMINISTRATION; PANCREAS TRANSPLANTATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FASTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; METABOLIC CLEARANCE RATE; MIDDLE AGED; POSTPRANDIAL PERIOD; PREMEDICATION; TACROLIMUS;

EID: 0031859571     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00237-1     Document Type: Conference Paper

References (5)

1. Aweeka FT, Benet LZ, Gambertoglio JG, et al: Clinical Pharmacol Ther 53:151, 1993
2. Lee C, Jusko W, Sheafer M et al: Clinical Pharmacol Ther 53:181, 1993
3. Christiaans M, van Duijnhoven E, et al: Transplantation Proc 30:(this issue), 1998
4. Horowitz M, Fraser RJ: Scand J Gastroenterol 213(suppl):7, 1995
5. van Duijnhoven E, Christiaans M, et al: Transplant Proc 30:(this issue), 1998